William Helfand began buying medically themed collectibles in the 1950s when he started working for Merck & Co. Over his 30-year career with the company, Helfand amassed thousands of posters and other old marketing paraphernalia, which were commi
Advertisement
The Scientist
Most Recent
Although pathogens have long been suspected to play a role in the neurodegeneration of Parkinson's and related diseases (see our December 2010 feature), very little is understood about the mechanics of the process. Specifically, scientists have been
Recent successes and ongoing efforts to develop a successful vaccine
Chronic users of acetaminophen (Tylenol) have a higher risk of developing blood cancer, according to a study published this week in the Journal of Clinical Oncology. The increased risk is small, but the finding adds to a growing body of literature th
Gay men are nearly twice as likely to report that they've had cancer as heterosexual men, according to a US health survey published in Cancer. Lesbians and bisexual female cancer survivors also report more health problems than heterosexual women in r
In a feat of computational biology, researchers design novel proteins capable of neutralizing a key influenza protein
A new vaccine that uses a persistent virus vector controlled SIV in 50 percent of tested monkeys
Does mitochondrial dysfunction lie at the heart of common, complex diseases like cancer and autism?
Clostridium difficile is evolving more robust toxicity, repeatedly attacking its victims, and driving the search for alternative therapies to fight the infection.
A promising gene therapy trial, derailed by cancerous side effects in a young patient, is set to reboot with the help of next generation gene-transfer vectors.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
